Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.
Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, Forman SA; Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Aversano T, et al. Among authors: terrin ml. JAMA. 2002 Apr 17;287(15):1943-51. doi: 10.1001/jama.287.15.1943. JAMA. 2002. PMID: 11960536 Clinical Trial.
Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study.
Zaret BL, Wackers FJ, Terrin ML, Ross R, Weiss M, Slater J, Morrison J, Bourge RC, Passamani E, Knatterud G, et al. Zaret BL, et al. Among authors: terrin ml. Am J Cardiol. 1992 Jan 1;69(1):1-9. doi: 10.1016/0002-9149(92)90667-n. Am J Cardiol. 1992. PMID: 1729855 Clinical Trial.
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML. Gore JM, et al. Among authors: terrin ml. Circulation. 1991 Feb;83(2):448-59. doi: 10.1161/01.cir.83.2.448. Circulation. 1991. PMID: 1899364 Clinical Trial.
Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Wackers FJ, Terrin ML, Kayden DS, Knatterud G, Forman S, Braunwald E, Zaret BL. Wackers FJ, et al. Among authors: terrin ml. J Am Coll Cardiol. 1989 Apr;13(5):998-1005. doi: 10.1016/0735-1097(89)90250-7. J Am Coll Cardiol. 1989. PMID: 2494246 Free article. Clinical Trial.
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, Bell WR, Knatterud G, Robertson TL, Terrin ML. Rao AK, et al. Among authors: terrin ml. J Am Coll Cardiol. 1988 Jan;11(1):1-11. doi: 10.1016/0735-1097(88)90158-1. J Am Coll Cardiol. 1988. PMID: 3121710 Free article. Clinical Trial.
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, et al. Sloan MA, et al. Among authors: terrin ml. Neurology. 1995 Apr;45(4):649-58. doi: 10.1212/wnl.45.4.649. Neurology. 1995. PMID: 7723950 Clinical Trial.
108 results